Implementation of i‑PARIHS-guided pulmonary rehabilitation in patients receiving oxygen by high‑flow nasal cannula. Download PDF Abstract Patients receiving high-flow nasal cannula (HFNC) oxygen therapy often experience dyspnea-related exercise fear, which limits adherence to pulmonary rehabilitation (PR). The integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework provides a structured approach to evidence translation, yet its application in HFNC-based PR remains limited.
This study evaluated the feasibility and preliminary effectiveness of an i‑PARIHS–guided strategy in reducing dyspnea and exercise fear while improving functional outcomes among patients receiving oxygen by HFNC. A two-cycle implementation project with historical controls was conducted in a tertiary hospital respiratory department, involving forty-five nurses and two cohorts of sixty patients each (one cohort receiving usual care as historical controls and one receiving the intervention). Twenty-two best-evidence publications were synthesized into seven topics and translated into fifteen review indicators across five audit domains—personnel structure, readiness assessment, exercise timing, training content, and education.
Interventions included structured PR training, motivational interviewing, goal setting, individualized education, and fixed multidisciplinary teams, implemented over four months. The primary outcomes were dyspnea (mMRC) and six-minute walk distance (6MWD); secondary outcomes were exercise self-efficacy and quality of life (SF-36). At baseline, adherence was below 80% for seven of the fifteen review indicators (implementation outcomes); after implementation, adherence exceeded 90% for all fifteen, with four reaching 100%.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.
Discover more from ChuckysCarnage
Subscribe to get the latest posts sent to your email.

